Stockscreener 앱 받기
7.7715
2.49%
0.1415
전일 마감가:
$7.63
열려 있는:
$7.53
하루 거래량:
87,585
Relative Volume:
0.07
시가총액:
$424.04M
수익:
$251.46M
순이익/손실:
$-892.87M
주가수익비율:
-10.95
EPS:
-0.71
순현금흐름:
$-336.30M
1주 성능:
-2.37%
1개월 성능:
-6.12%
6개월 성능:
-79.53%
1년 성능:
-88.08%
1일 변동 폭
$7.53
$7.86
1주일 범위
$7.43
$8.39
52주 변동 폭
$5.26
$75.20
깅코 바이오웍스 홀딩스 Stock (DNA) Company Profile
명칭
Ginkgo Bioworks Holdings Inc
전화
(877) 442-5362
주소
27 DRYDOCK AVENUE, BOSTON
깅코 바이오웍스 홀딩스 Stock (DNA) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-05-15 | 다운그레이드 | BTIG Research | Neutral → Sell |
| 2024-05-10 | 다운그레이드 | William Blair | Mkt Perform → Underperform |
| 2023-11-14 | 다운그레이드 | Raymond James | Outperform → Mkt Perform |
| 2023-11-09 | 다운그레이드 | BTIG Research | Buy → Neutral |
| 2023-06-02 | 다운그레이드 | Goldman | Neutral → Sell |
| 2023-05-11 | 다운그레이드 | William Blair | Outperform → Mkt Perform |
| 2022-11-29 | 개시 | Berenberg | Buy |
| 2022-10-04 | 개시 | Morgan Stanley | Equal-Weight |
| 2022-05-18 | 다운그레이드 | BofA Securities | Neutral → Underperform |
| 2022-03-02 | 재개 | Cowen | Outperform |
| 2022-02-23 | 개시 | Goldman | Neutral |
| 2022-02-01 | 개시 | BofA Securities | Neutral |
| 2022-01-28 | 개시 | BofA Securities | Buy |
| 2022-01-07 | 개시 | BTIG Research | Buy |
| 2021-11-29 | 개시 | Jefferies | Buy |
| 2021-10-13 | 개시 | Raymond James | Outperform |
| 2021-10-12 | 개시 | William Blair | Outperform |
| 2021-09-20 | 개시 | HSBC Securities | Buy |
모두보기
깅코 바이오웍스 홀딩스 주식(DNA)의 최신 뉴스
Ginkgo Bioworks Announces Date of Third Quarter 2024 Results Presentation - BioSpace
Vanguard Group Inc's Strategic Reduction in Ginkgo Bioworks Holdings Inc - GuruFocus.com
Here's Why Ginkgo Bioworks Holdings, Inc. (DNA) Fell More Than Broader Market - MSN
With 48% ownership, Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) has piqued the interest of institutional investors - Yahoo Finance
Ginkgo Bioworks (DNA): A Leader in Cell Programming and Genetic Diagnostics - Insider Monkey
10 Most Promising Gene Editing Stocks to Buy According to Hedge Funds - Insider Monkey
Ginkgo Bioworks Holdings, Inc. (DNA) Outpaces Stock Market Gains: What You Should Know - MSN
Forbes J M & Co. LLP Invests $1.02 Million in Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) - MarketBeat
PFG Investments LLC Invests $1.54 Million in Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) - MarketBeat
Major Boston biotech company begins layoffs this week - MSN
Ginkgo Bioworks (NYSE:DNA) Shares Up 5%Here's What Happened - MarketBeat
Equitec Proprietary Markets LLC Has $99,000 Holdings in Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) - MarketBeat
Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) Sees Significant Growth in Short Interest - MarketBeat
Ginkgo Bioworks (NYSE:DNA) Trading 5.9% HigherStill a Buy? - MarketBeat
Exchange Traded Concepts LLC Has $2.99 Million Holdings in Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) - MarketBeat
Down 86% This Year, Is Ginkgo Bioworks Stock a Bargain Now? - MSN
Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) Shares Sold by Squarepoint Ops LLC - MarketBeat
Algert Global LLC Takes $36,000 Position in Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) - MarketBeat
Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) Receives $4.16 Consensus Target Price from Analysts - MarketBeat
Ginkgo Bioworks Holdings Inc (DNA) Q2 2024 Earnings Call Highlights: Strategic Restructuring ... By GuruFocus - Investing.com Canada
Ginkgo Bioworks executive sells over $10k in company stock By Investing.com - Investing.com Australia
Ginkgo Bioworks exec sells over $2500 in stock By Investing.com - Investing.com Canada
Ginkgo Bioworks executive sells over $10k in company stock - Investing.com
Ginkgo Bioworks exec sells over $2500 in stock - Investing.com
Transforming Healthcare From The Inside Out, Nanorobots Are Revolutionizing Treatment With Precision At The Nanoscale: A Report by TNR, The Niche Research - GlobeNewswire Inc.
Green Alpha Advisors LLC Decreases Stake in Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) - MarketBeat
Mackenzie Financial Corp Takes Position in Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) - MarketBeat
Lesaffre strengthens its Research, Development & Innovation (RD&I) with the acquisition of Altar, a company owned by Ginkgo Bioworks - Yahoo Finance
Where are the Opportunities in (DNA) - Stock Traders Daily
Revenues Tell The Story For Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) As Its Stock Soars 33% - Simply Wall St
Virica Biotech and Ginkgo Bioworks Announce Partnership to Accelerate AAV Gene Therapy Manufacturing - Yahoo Finance
Renaissance Technologies LLC Makes New $2.13 Million Investment in Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) - MarketBeat
After Plunging -40.22% in 4 Weeks, Here's Why the Trend Might Reverse for Ginkgo Bioworks (DNA) - MSN
Nanobots in Healthcare Research Report 2024: A $7.1 Billion Market in 2023Global Forecast to 2030 - GlobeNewswire Inc.
Rhumbline Advisers Sells 1,331,930 Shares of Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) - MarketBeat
Wellington Wealth Strategies LLC. Makes New Investment in Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) - MarketBeat
Benjamin F. Edwards & Company Inc. Raises Holdings in Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) - Defense World
Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) Stock Position Lifted by Benjamin F. Edwards & Company Inc. - MarketBeat
Ginkgo Bioworks Holdings, Inc. (DNA) Stock Slides as Market Rises: Facts to Know Before You Trade - MSN
933,898 Shares in Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) Purchased by XTX Topco Ltd - MarketBeat
(DNA) Trading Advice - Stock Traders Daily
Novus, Ginkgo Bioworks partner to develop new feed additives - FeedStrategy.com
NOVUS Leverages Ginkgo Bioworks to Develop Innovative Feed Additives for Animal Agriculture - PR Newswire
What's Going On With Ginkgo Bioworks Stock This Week? - MSN
깅코 바이오웍스 홀딩스 (DNA) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.75%
0.20%
자본화:
|
볼륨(24시간):